Skip to content

Clinical trials

Phase 3 Obesity trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Country / region: Belgium Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20051
20061
20081
20112
20161
20171
20182
20191
20211
20222
20234
20241
20256
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14
Completed12
Active, not recruiting7
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S14
Eli Lilly and Company8
Boehringer Ingelheim4
Sanofi4
Amgen3
Hoffmann-La Roche1
Rhythm Pharmaceuticals, Inc.1
Satiety, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity36
Overweight15
Diabetes Mellitus, Type 24
Nutrition Disorders3
Atherosclerosis1
Body Weight1
Cardiovascular Diseases1
Colitis, Ulcerative1
Crohn Disease1
Diabetes Mellitus1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.